A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?

Table 3

The laboratory parameters in 1281 patients in 4 groups with Kawasaki disease.

	Laboratory parameter	Group 1 ()	Group 2 ()	Group 3 ()	Group 4 ()	value
Baseline data	WBC count (10^3/mm^3)					0.764
	Neutrophils (%)					<0.001
	CRP (mg/L)					<0.001
Data after treatment	WBC count (10^3/mm^3)					0.095
	Neutrophils (%)					0.039
	CRP (mg/L)					<0.001

Expressed as . CRP: C-reactive protein; WBC: white blood cell.